Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 73

1.

A long-surviving case of gastric cancer with main portal vein tumor thrombus after surgical resection and postoperative S-1 therapy.

Sato S, Nagai E, Taki Y, Watanabe M, Takahashi M, Kyoden Y, Ohata K, Kanemoto H, Oba N, Taku K, Suzuki M, Takagi M.

Clin J Gastroenterol. 2016 Aug;9(4):233-7. doi: 10.1007/s12328-016-0665-4.

PMID:
27318995
2.

Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G).

Yamazaki K, Nagase M, Tamagawa H, Ueda S, Tamura T, Murata K, Eguchi Nakajima T, Baba E, Tsuda M, Moriwaki T, Esaki T, Tsuji Y, Muro K, Taira K, Denda T, Funai S, Shinozaki K, Yamashita H, Sugimoto N, Okuno T, Nishina T, Umeki M, Kurimoto T, Takayama T, Tsuji A, Yoshida M, Hosokawa A, Shibata Y, Suyama K, Okabe M, Suzuki K, Seki N, Kawakami K, Sato M, Fujikawa K, Hirashima T, Shimura T, Taku K, Otsuji T, Tamura F, Shinozaki E, Nakashima K, Hara H, Tsushima T, Ando M, Morita S, Boku N, Hyodo I.

Ann Oncol. 2016 Aug;27(8):1539-46. doi: 10.1093/annonc/mdw206.

PMID:
27177863
3.

Relation Between Physicians' Work Lives and Happiness.

Eckleberry-Hunt J, Kirkpatrick H, Taku K, Hunt R, Vasappa R.

South Med J. 2016 Apr;109(4):207-12. doi: 10.14423/SMJ.0000000000000437.

PMID:
27043800
4.

Predictability of antitumor efficacy of cetuximab plus irinotecan based on skin rash severity according to observation period in patients with metastatic colorectal cancer following failure of fluorouracil, irinotecan and oxaliplatin.

Horie Y, Yamazaki K, Funakoshi T, Hamauchi S, Taniguchi H, Tsushima T, Todaka A, Machida N, Taku K, Fukutomi A, Onozawa Y, Yasui H, Mizukami T, Izawa N, Hirakawa M, Tsuda T, Nakajima T, Boku N.

Mol Clin Oncol. 2015 Sep;3(5):1029-1034.

5.

Personally important posttraumatic growth in adolescents: The effect on self-esteem beyond commonly defined posttraumatic growth.

Taku K, McDiarmid L.

J Adolesc. 2015 Oct;44:224-31. doi: 10.1016/j.adolescence.2015.08.001.

PMID:
26302333
6.

Post-traumatic Stress and Growth Among Medical Student Volunteers After the March 2011 Disaster in Fukushima, Japan: Implications for Student Involvement with Future Disasters.

Anderson D, Prioleau P, Taku K, Naruse Y, Sekine H, Maeda M, Yabe H, Katz C, Yanagisawa R.

Psychiatr Q. 2016 Jun;87(2):241-51. doi: 10.1007/s11126-015-9381-3.

PMID:
26169115
7.

Core beliefs shaken by an earthquake correlate with posttraumatic growth.

Taku K, Cann A, Tedeschi RG, Calhoun LG.

Psychol Trauma. 2015 Nov;7(6):563-9. doi: 10.1037/tra0000054.

PMID:
26010110
8.

Retrospective analysis of severe neutropenia in patients receiving concomitant administration of docetaxel and clarithromycin.

Tsuji D, Kamezato M, Daimon T, Taku K, Hatori M, Ikeda M, Hayashi H, Inoue K, Eto T, Itoh K.

Chemotherapy. 2013;59(6):407-13. doi: 10.1159/000362437.

PMID:
25011542
9.

Multiple effects of swelling by sodium bicarbonate after delignification on enzymatic saccharification of rice straw.

Kahar P, Taku K, Tanaka S.

J Biosci Bioeng. 2013 Dec;116(6):725-33. doi: 10.1016/j.jbiosc.2013.05.036.

PMID:
23830033
10.

Phase I study of highly selective inhibitor of VEGFR tyrosine kinase, tivozanib, in Japanese patients with solid tumors.

Niwakawa M, Yamaguchi R, Onozawa Y, Yasui H, Taku K, Naito T, Akinaga S, Boku N, Yamamoto N.

Cancer Sci. 2013 Aug;104(8):1039-44. doi: 10.1111/cas.12197.

11.

Serum lipid-improving effect of soyabean β-conglycinin in hyperlipidaemic menopausal women.

Ma D, Taku K, Zhang Y, Jia M, Wang Y, Wang P.

Br J Nutr. 2013 Nov 14;110(9):1680-4. doi: 10.1017/S0007114513000986.

PMID:
23561330
12.

Letters to the editor.

Messina M, Melby MK, Kronenberg F, Kurzer MS, Taku K.

Menopause. 2013 Mar;20(3):359-61. doi: 10.1097/GME.0b013e318284e64a. No abstract available.

PMID:
23435036
13.

Nutrition support for head and neck squamous cell carcinoma patients treated with chemoradiotherapy: how often and how long?

Ishiki H, Onozawa Y, Kojima T, Hironaka S, Fukutomi A, Yasui H, Yamazaki K, Taku K, Machida N, Boku N, Hashimoto T, Nishimura T.

ISRN Oncol. 2012;2012:274739. doi: 10.5402/2012/274739.

14.

Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials.

Taku K, Melby MK, Kronenberg F, Kurzer MS, Messina M.

Menopause. 2012 Jul;19(7):776-90. doi: 10.1097/gme.0b013e3182410159. Review.

PMID:
22433977
15.

Feasibility of mFOLFOX6 as the adjuvant treatment after curative resection of metastases from colorectal cancer in Japanese patients.

Machida N, Yoshizaki K, Boku N, Yamazaki K, Onozawa Y, Fukutomi A, Yasui H, Taku K.

Int J Clin Oncol. 2013 Apr;18(2):279-84. doi: 10.1007/s10147-012-0374-z.

PMID:
22367535
16.

Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancer.

Tsushima T, Hironaka S, Boku N, Machida N, Yamazaki K, Yasui H, Fukutomi A, Todaka A, Taniguchi H, Onozawa Y, Taku K.

Int J Clin Oncol. 2013 Feb;18(1):10-6. doi: 10.1007/s10147-011-0335-y.

PMID:
22020563
17.

Soy isoflavones for osteoporosis: an evidence-based approach.

Taku K, Melby MK, Nishi N, Omori T, Kurzer MS.

Maturitas. 2011 Dec;70(4):333-8. doi: 10.1016/j.maturitas.2011.09.001. Review.

PMID:
21958941
18.

Phase I study of cediranib in combination with cisplatin plus fluoropyrimidine (S-1 or capecitabine) in Japanese patients with previously untreated advanced gastric cancer.

Satoh T, Yamada Y, Muro K, Hayashi H, Shimada Y, Takahari D, Taku K, Nakajima TE, Shi X, Brown KH, Boku N.

Cancer Chemother Pharmacol. 2012 Feb;69(2):439-46. doi: 10.1007/s00280-011-1723-8.

PMID:
21853311
19.

Leptomeningeal carcinomatosis associated with gastric cancer.

Tomita H, Yasui H, Boku N, Nakasu Y, Mitsuya K, Onozawa Y, Fukutomi A, Yamazaki K, Machida N, Taku K, Todaka A, Taniguchi H, Tsushima T.

Int J Clin Oncol. 2012 Aug;17(4):361-6. doi: 10.1007/s10147-011-0301-8.

PMID:
21847535
20.

Comparative trial of two intravenous doses of granisetron (1 versus 3 mg) in the prevention of chemotherapy-induced acute emesis: a double-blind, randomized, non-inferiority trial.

Tsuji D, Kim YI, Taku K, Nakagaki S, Ikematsu Y, Tsubota H, Maeda M, Hashimoto N, Kimura M, Daimon T.

Support Care Cancer. 2012 May;20(5):1057-64. doi: 10.1007/s00520-011-1185-x.

PMID:
21590327
Items per page

Supplemental Content

Loading ...
Support Center